by steven | Mar 20, 2021 | Blog
NHS reform is the problem, not the solution Posted in: Data, politics and policy, Health, Political ideologies, Public services, UK politics Tony Hockley is Director of the Policy Analysis Centre and a Visiting Senior Fellow in the LSE...
by deborah | Mar 20, 2021 | Blog
Institute for Public Policy Research report: NHS needs an additional £2.2bn a year until 2025/26 to tackle elective care backlogThe Institute for Public Policy Research (IPPR) highlight the significant backward step Covid-19 has caused for patient outcomes and the...
by steven | Mar 20, 2021 | Blog
NHSE&I released statistics on referral to treatment (RTT) waiting times for elective care. Key finding include: Patients on the overall NHSE waiting list for 52 weeks or more rose from 224,205 in December to 304,044 in January, prior to the pandemic in February...
by ashley | Mar 7, 2021 | Blog
Cancer Research UK has appointed Angela Morrison as chief operating officer and Richard Newsome as chief technology officer, as part of its restructure following the impact of COVID-19. In the newly created chief operating officer role, Morrison will sit on...
by deborah | Mar 4, 2021 | Blog
Evaluation of service transformation needs more money, staff and focus. 1 March 2021 | Professor Mike Roberts There is a need to change how rapid service evaluation is funded, co-ordinated and delivered, not just during but beyond the pandemic to enable more effective...
by steven | Mar 4, 2021 | Blog
Life-extending drug for incurable breast cancer approved for NHS use. About 3,300 women a year may benefit from decision to approve ribociclib Women with incurable advanced breast cancer will be able to get a drug from the NHS that can potentially extend...
Recent Comments